217743 - An observational, retrospective database post-authorisation safety study (PASS) to assess trends and changes over time in incidence of anal cancer and feasibility for a case-control study in European countries that introduced Cervarix in their National Immunisation Programmes (NIP) (EPI-HPV-099 VS EUR DB)

04/08/2021
01/07/2024
EU PAS number:
EUPAS42373
Study
Finalised
Documents
Study protocol
Initial protocol
English (540.92 KB - PDF) View document
Study results
Study results
English (6.38 MB - PDF) View document
Study report
Other information